Literature DB >> 10878703

Androgen deprivation in males is associated with decreased central arterial compliance and reduced central systolic blood pressure.

F Dockery1, C Rajkumar, S Agarwal, J Waxman, C J Bulpitt.   

Abstract

The higher incidence of coronary artery disease in men is often attributed to androgens. Arterial compliance or 'stiffness' is increasingly regarded as a modifiable risk factor for cardiovascular disease. We wanted to look at the effects of complete androgen withdrawal, on arterial compliance in men. We performed arterial compliance studies on 12 men with complete androgen deprivation as treatment for prostate cancer, and on 12 age-matched healthy controls. Central pulse wave velocities were significantly higher in the androgen-deprived men (14.2 +/- 2.7 vs 11.8 +/- 1.6 m/sec, P = 0. 02). The cases tended to have higher brachial systolic pressures than controls though this difference was not significant (P = 0.2). We conclude that androgen withdrawal is associated with a reduction in central arterial compliance. Conversely androgen withdrawal does not affect peripheral arterial compliance. It is unlikely that the presence of normal concentrations of androgens can explain the sex difference in mortality rates. Longitudinal studies are needed for further evaluation. Journal of Human Hypertension (2000) 14, 395-397

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878703     DOI: 10.1038/sj.jhh.1001028

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

Review 1.  Effects of antihypertensive therapy on sexual activity in hypertensive men.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

2.  The Relationship Between Cancer and Functional and Structural Markers of Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis.

Authors:  Yuhong Diao; Zhixing Liu; Li Chen; Weiping Zhang; Dandan Sun
Journal:  Front Cardiovasc Med       Date:  2022-05-04

3.  Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer.

Authors:  Paul L Nguyen; Petr Jarolim; Shehzad Basaria; Jonah P Zuflacht; Jessica Milian; Samoneh Kadivar; Powell L Graham; Andrew Hyatt; Philip W Kantoff; Joshua A Beckman
Journal:  J Am Heart Assoc       Date:  2015-04-20       Impact factor: 5.501

4.  Androgen-Deprivation Therapy and Cardiovascular Disease Risk - The Role of Exercise in Prostate Cancer Treatment.

Authors:  Bradley Wall
Journal:  Front Oncol       Date:  2016-09-19       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.